RSHO™ CBD hemp oil is available in four varieties of high-quality, pure cannabidiol oil, including Green Label, Blue Label, Gold Label, and Special Blend. RSHO™ contains between 50mg and 190mg of cannabidiol per 0.5 gram serving. Each of the pure CBD hemp oil varieties come in 3 gram and 10 gram applicators. For regular users, 3 packs and 6 packs of applicators are available.
Cannabidiol is insoluble in water but soluble in organic solvents such as pentane. At room temperature, it is a colorless crystalline solid. In strongly basic media and the presence of air, it is oxidized to a quinone. Under acidic conditions it cyclizes to THC. The synthesis of cannabidiol has been accomplished by several research groups.
Our supplements are derived from industrial hemp, not to be confused with marijuana. Industrial hemp is a legal plant from which many popular foods are harvested. To create our products, we extract a full spectrum of compounds from the hemp plant. This full spectrum contains a stunningly varied array of phyto-cannabinoids, including CBD, CBC, CBG, CBN, and much more. Our extracts contain less than 0.3% concentration of THC, the component from Cannabis sativa L. that causes a high.
Cannabidiol (CBD) use is skyrocketing in the US. Between 2014 and 2018, the sales of CBD increased by 474%. And if you think that kind of growth can't continue, sales are projected to increase another 353% by 2022. Clearly, people all over are discovering that this all-natural, cannabis-derived supplement is a great way to support their health. (See References)
I can be a pretty caffeine sensitive person — a cup or two can occasionally provoke anxiety attacks and a racing heartbeat. Not so with this coffee! Delicious, smooth, and very relaxing but with the same mentally energizing effects of your standard joe. The CBD is extremely subtle and non-psychoactive, but it definitely works wonders. Highly recommended!
As a consumer, you can look at the manufacturer's website to see whether they batch-test their products, or ask them directly. You could also send a sample of your CBD oil to a testing facility yourself, something Bonn-Miller says he would do if he were trying to treat someone with a severe issue such as epilepsy. Testing can also determine whether the product contains pesticides, heavy metals, or other toxins.
At this point, everyone is pretty familiar with caffeine. As a stimulant, caffeine increases the activity in your central nervous system, which can help you feel more awake and focused. Unfortunately, caffeine’s stimulatory effects can also make some users feel restless, shaky, and anxious. In contrast, many people believe CBD to be a soothing ingredient for the body that leaves your mind unaffected. That is why CBD could provide a nice Ying to caffeine’s Yang, evening out your morning buzz.
It’s a truism to state that pain is an inevitable part of life. And it’s true that we all, from time to time, experience pain that is short-lived and treatable. But those who deal with chronic pain know the debilitating, life-sucking reality of this condition. And traditional medications often come with long lists of side effects which can be as debilitating as the pain itself.
"A CBD company may create a CBD oil, test it, and use the test results to create their label," Bonn-Miller says. "The problem is if they never test their product again, or they test it once a year, you have no idea whether each batch is the same as the first one that they used to create the label. The vast majority of companies are not using manufacturing standards that assure product consistency over time. Companies should be testing every batch they make and tossing batches that don't fall within the specs of their label."
Laboratory evidence indicated that cannabidiol may reduce THC clearance, increasing plasma concentrations which may raise THC availability to receptors and enhance its effect in a dose-dependent manner. In vitro, cannabidiol inhibited receptors affecting the activity of voltage-dependent sodium and potassium channels, which may affect neural activity. A small clinical trial reported that CBD partially inhibited the CYP2C-catalyzed hydroxylation of THC to 11-OH-THC.